Healthcare IT  | New York

Cecelia Health Closes $13 Million Series B, to Help People with Diabetes and Other Chronic Conditions

Cecelia Health, a tech-enabled diabetes and chronic disease management company, closed a $13 million Series B funding round co-led by Rittenhouse Ventures and Endo Investors, with investments from Boston Millennia Partners, SustainVC, G100 Capital, and others. The funds will scale the adoption of its tech-enabled coaching and telemedicine solutions and expand digital health capabilities. [Full story]